
The 2026 OIG antipsychotic report puts the review trail—not just the rate—under scrutiny
OIG found serious failures in a focused set of nursing-home inspections, including missed pharmacist concerns and dose-reduction opportunities. The practical response is a review record that shows what was assessed, raised, answered, and revisited.



